Stocktoria
Intellia Therapeutics, Inc. NTLA
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2016-05-06
Chart by TradingView
2/9
Piotroski F — financial health
-6.12
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $67.7M | $57.9M | $36.3M | $52.1M | $33.1M |
| Operating income | -$441.0M | -$534.3M | -$515.3M | -$458.2M | -$267.9M |
| Net income | -$412.7M | -$519.0M | -$481.2M | -$474.2M | -$267.9M |
| Operating cash flow | -$394.7M | -$348.9M | -$394.1M | -$333.3M | -$225.0M |
| Free cash flow | -$395.9M | -$354.7M | -$408.1M | -$346.8M | -$237.8M |
| Total assets | $842.1M | $1.2B | $1.3B | $1.5B | $1.3B |
| Total liabilities | $170.7M | $319.1M | $250.8M | $284.5M | — |
| Shareholders' equity | $671.4M | $872.0M | $1.1B | $1.2B | $1.0B |
| Ratios | |||||
| Operating margin | -651.7% | -923.1% | -1420.5% | -879.0% | -810.4% |
| Net margin | -609.9% | -896.8% | -1326.5% | -909.8% | -810.5% |
| FCF margin | -585.0% | -612.8% | -1124.9% | -665.5% | -719.4% |
| Return on assets | -49.0% | -43.6% | -37.0% | -31.2% | -20.7% |
| Return on equity | -61.5% | -59.5% | -45.8% | -38.4% | -25.8% |
| Current ratio | 5.08 | 5.77 | 8.67 | 9.61 | 6.11 |
| Revenue growth | 16.9% | 59.6% | -30.4% | 57.7% | -43.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| ARK Investment Management LLC | 14,509,247 | $186.0M |
| Point72 Asset Management, L.P. | 297,011 | $3.8M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.12 (distress)
- Working capital / assets 0.503
- Retained earnings / assets -3.076
- EBIT / assets -0.524
- Equity / liabilities 3.932
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001652130 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.